In today’s AI-forward healthcare world, several technologies boast their ability to identify pulmonary nodules using sophisticated algorithms. But at Eon, we believe that identification alone is not enough.

‍

To truly make a difference in patient outcomes, you must be able to track pulmonary nodules over time, guide patients through personalized care pathways, and ensure they receive the follow-up they need. Because when it comes to pulmonary nodules, early identification is only the first step – tracking is what saves lives.

‍

Beyond Identification to Tracking Pulmonary Nodules

‍

While advancements in artificial intelligence have made it more efficient to detect lung nodules from imaging scans, the real work begins after the first abnormality is identified. Successful tracking of pulmonary nodules requires dynamic care plan generation, longitudinal monitoring, and ongoing patient engagement. Without these steps, nodules can grow unnoticed, and opportunities for early intervention are lost.

‍

At Eon, we’ve built our platform around the very idea that identification is only the first part of the problem. Once a pulmonary nodule is found, a reliable system must:

‍

• Risk stratify the nodule based on characteristics like size, location, growth rate, and patient history
• Generate a care plan that matches the patient’s risk level and appropriate clinical guidelines
• Route patients to the correct specialists – whether that’s a pulmonologist, thoracic surgeon, or oncologist
• Monitor follow-up actions and adherence to ensure no delays or gaps in care
• Continuously adapt the care plan as the nodule progresses, remains stable, or is treated

‍

Tracking Pulmonary Nodules Requires Action, Not Just Alerts

‍

What sets advanced platforms like Eon’s apart is that they don't stop at flagging a finding. Instead, they manage the entire longitudinal care journey, turning insight into action.

‍

By using intelligent automation and structured workflows, our platform ensures that every pulmonary nodule is not only recorded, but tracked over time, linked to appropriate follow-up steps based on Fleischner or Lung-RADS guidelines, and escalated (when necessary) so patients are seen at the right time by the right care team.

‍

This level of proactive management drastically improves adherence, reduces delays in diagnosis, and drives earlier treatment – all of which contribute to improved survival rates.

Care Plan Generation: The Key to Adherence and Better Outcomes

‍

One of the most overlooked steps in pulmonary nodule tracking is care plan generation. Without a clear, documented, and communicated plan, patients often don’t return for follow-up, especially if they are asymptomatic.

‍

Our platform auto-generates and delivers individualized care plans to patients, ensures providers are notified of next steps, and supports care coordinators and navigators in patient outreach. That continuity and comprehensiveness is what turns a system of detection into a system of early intervention.

‍

The Bottom Line: Better Patient Outcomes Start with Better Tracking

‍

If your health system wants to truly improve lung cancer outcomes, the answer isn’t just AI that can spot a nodule – it’s a solution that can track pulmonary nodules across time, across departments, and across care transitions.

‍

Eon’s intelligent care platform was built to solve this challenge. We partner with health systems to:

‍

• Identify nodules with 98% accuracy
• Track patient progress across multiple specialties, using a multitude of data inputs
• Adapt and update care plans based on changing risk and steps taken
• Drive adherence with intelligent, timely follow-up

‍

Catching a nodule is one thing, but following through to ensure a positive outcome is everything.

‍

Ready to move beyond identification and start tracking pulmonary nodules the right way? Learn more about how Eon is driving early detection through intelligent tracking.